• Cy7 NHS Ester: Practical Labeling and QC Guide

  2026-08-18

  Cy7 NHS ester is a water-soluble near-infrared dye for bioimaging that enables labeling of accessible amino groups on proteins and peptides. It is suited to aqueous labeling of sensitive biomolecules, but not to targets lacking primary amines or workflows that require long-term storage of prepared dye solutions.

• Risedronate Sodium: From Bone to Lung Research

  2026-08-18

  Risedronate Sodium combines a validated FPPS-inhibition mechanism for bone metabolism research with a preclinical inhalation strategy that targets alveolar macrophages. This guide translates those findings into practical cell, formulation, aerosol, and animal-model workflows while emphasizing solubility, deposition, and assay controls.

• AIBP-LRP2 Control of CXCR4+ Collateral Growth

  2026-08-17

  Zhu et al. identify an AIBP-LRP2-HDL-miR-223 pathway that suppresses CXCR4+ stemlike capillary endothelial cells and limits collateral circulation after ischemia. The study proposes a two-phase model in which CXCR4+ endothelial cells first expand and subsequently acquire arterial characteristics, offering a mechanistic framework for revascularization research in peripheral artery disease.

• Sumatriptan Metabolism: CYP and MAO Revisited

  2026-08-17

  The reference study challenges the prevailing view that sumatriptan is metabolized almost exclusively by MAO A, showing that CYP1A2, CYP2C19, and CYP2D6 also mediate sequential N-demethylation. Its recombinant-enzyme and HPLC–MS design provides a useful framework for separating CYP-dependent and MAO-dependent routes when interpreting drug biotransformation.

• GS967: Cardiac Late Sodium Current Inhibitor

  2026-08-16

  GS967 enables targeted interrogation of pathological late sodium influx in ventricular myocytes, aging-heart models, and triggered arrhythmia assays. Its selective profile supports mechanism-focused electrophysiology workflows that connect Nav1.5 activity with repolarization, calcium handling, and diastolic dysfunction.

• Cannabis Terpenes Activate A2A Receptors in Pain

  2026-08-15

  Schwarz and colleagues show that five Cannabis sativa terpenes reduce nociceptive behavior in mouse models of chemotherapy-induced peripheral neuropathy and inflammatory pain. Behavioral, pharmacological, genetic, biochemical, and computational evidence converges on adenosine A2A receptor activation, while the absence of conditioned place preference suggests a potentially non-rewarding analgesic profile that requires further validation.

• Phage-Layer Interferometry for Phage Therapy

  2026-08-14

  The reference study introduces phage-layer interferometry (PLI) as a quantitative companion diagnostic for screening therapeutic bacteriophages and as a platform for bacterial detection. Its central advance is the ability to monitor phage–bacterium interactions in complex, opaque media while separating binding behavior from lysis-related activity, creating opportunities for automation and more rational phage-cocktail design.

• Cy7 NHS Ester: Practical Labeling Guide

  2026-08-14

  Cy7 NHS ester is a water-soluble near-infrared dye for bioimaging that supports amino-group labeling of proteins and peptides without requiring an organic co-solvent during the labeling step. It is best suited to freshly prepared conjugation workflows and light-protected assays, not applications requiring long-term storage of dye solutions.

• Oleanolic Acid in Liposome Assay Workflows

  2026-08-13

  Oleanolic acid offers a practical lipophilic payload for connecting inducible nitric oxide synthase induction and immune pathway studies with advanced dual-loaded liposome development. This guide emphasizes solvent control, quantitative encapsulation analysis, and nanoparticle exclusion chromatography for more reliable antiviral and inflammation pathway research.

• Sulfo-NHS-SS-Biotin: Reversible Surface Labeling

  2026-08-13

  Sulfo-NHS-SS-Biotin is a water-soluble, amine-reactive reagent for reversible protein and cell-surface labeling. Its NHS ester forms amide bonds with primary amines, while its disulfide linker permits reductive release of the biotin label.

• GS967: Cardiac Late Sodium Current Inhibitor

  2026-08-12

  GS967 enables targeted interrogation of pathological late sodium influx in ventricular myocytes, aging models, isolated hearts, and ischemia-related arrhythmia assays. This guide translates its potency and voltage-sensitive profile into practical workflows, assay controls, and troubleshooting strategies for reproducible cardiac electrophysiology research.

• (+)-Bicuculline Protocol and QC Guide

  2026-08-12

  (+)-Bicuculline is a practical GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, synaptic NMDA receptor signaling modulation, and related neuronal readouts. This dossier-based guide covers preparation, storage, controls, and interpretation; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or medical applications.

• Sulfo-Cy3 NHS Ester for Protein Uptake Assays

  2026-08-11

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for water-compatible labeling of proteins, peptides, and amino-bearing particles. Its NHS ester chemistry supports uptake, binding, and trafficking assays relevant to the AIBP–LRP2–HDL–miR-223 pathway while reducing solubility and aggregation problems.

• Nascent Cone Precursors in Human Retinoblastoma

  2026-08-11

  A Cell Death and Disease study uses RB1-deficient human retinal organoids and longitudinal single-cell analysis to identify ATOH7+/RXRγ+ nascent cone precursors as the earliest cellular origin of human retinoblastoma. The work separates the retinal cells most sensitive to RB1 loss from the cells that ultimately initiate tumors, providing a useful framework for disease modeling and therapeutic target discovery.

• COX-2 in Venom-Induced Muscle Ischemia and Repair

  2026-08-10

  This study shows that the cyclooxygenase-2 pathway has a time-dependent role after Bothrops asper venom injury: it helps preserve vascular integrity during acute ischemia, while its early inhibition later increases proangiogenic and matrix-remodeling signals. The findings position Lumiracoxib as a mechanistic probe for dissecting how prostaglandin signaling coordinates muscle ischemia, revascularization, and repair.

16774 records 1/1119 page Next 12345 下5页 Last page